Other

Change at the top for Biogen after Alzheimer's drug flops

Biogen will replace its CEO and largely abandon marketing of its controversial Alzheimer's drug Aduhelm less than a year after the medication's launch triggered a backlash from experts, doctors and insurers.

Diseases, Conditions, Syndromes

Application for iPhone may help monitor Parkinson's disease

(Medical Xpress) -- Researchers at the Georgia Tech Research Institute (GTRI) have developed a novel iPhone application that may enable persons with Parkinson's disease and certain other neurological conditions to use the ...

Medications

COVID-19: Physician co-authors analysis of antiviral drug

In a small group of patients hospitalized with severe complications of COVID-19 and treated with the experimental antiviral drug remdesivir, clinical improvement was observed in 68% of patients treated, according to an analysis ...

Genetics

New drugs more likely to be approved if backed up by genetics

A new drug candidate is more likely to be approved for use if it targets a gene known to be linked to the disease; a finding that can help pharmaceutical companies to focus their drug development efforts. Emily King and colleagues ...

page 7 from 40